Detalles de la búsqueda
1.
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Clin Infect Dis
; 75(1): e792-e804, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537835
2.
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.
Vaccines (Basel)
; 11(10)2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896930
3.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
EBioMedicine
; 91: 104563, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099842
4.
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.
Vaccines (Basel)
; 10(7)2022 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891246
5.
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
mBio
; 13(6): e0131122, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36383021
6.
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
medRxiv
; 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441179
7.
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Elife
; 112022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36226829
8.
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
mBio
; 13(4): e0142322, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946814
9.
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Front Immunol
; 12: 747830, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858404
10.
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol
; 12: 742914, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659237
11.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
medRxiv
; 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441164
12.
Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial.
EClinicalMedicine
; 27: 100517, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073219
13.
Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells.
Eur J Pharm Biopharm
; 142: 449-459, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31326581
14.
Highly versatile immunostimulating nanocapsules for specific immune potentiation.
Nanomedicine (Lond)
; 9(15): 2273-89, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673264
Resultados
1 -
14
de 14
1
Próxima >
>>